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ABSTRACT
Somatoform Disorder: Treatment Utilization and
Cost by Mental Health Professions
Lori Morton
School of Family Life, BYU
Master of Science
Somatoform disorder is a prevalent mental health disorder in the United States. This
disorder costs the United States one billion dollars annually. Medical providers report
somatoform disorder is difficult to treat. Previous studies have shown that Cognitive Behavioral
Therapy (CBT) is effective at reducing symptoms of somatoform disorder. Unfortunately, little
research has been done on treatment outcomes and cost of somatoform disorder, particularly by
profession to reduce health care costs for somatoform patients and providers. Administrative
data from CIGNA for 149 somatoform disorder cases were analyzed to determine the cost,
number of sessions, dropout rates, and recidivism rates for somatoform disorder. These same
variables for somatoform disorder were also analyzed by profession for medical doctors,
psychologists, master’s nurses, master’s social workers, marriage and family therapists, and
professional counselors. Descriptive statistics showed that the recidivism rates and number of
sessions for somatoform disorder is higher than average. Drop-out rates were consistent with the
average. Analyses revealed no significant difference in total cost by profession, but did indicate a
significant difference in cost per session for medical doctors. Analyses indicate lower level
(M.S.) providers have no significant difference in drop-out rates and recidivism rates compared
to higher level (Ph.D.) providers.
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Introduction
Somatoform disorder consists of physical complaints that cannot be fully explained by a
known medical condition or substance use. This is different from psychosomatic disorders that
consist of a disease caused or exacerbated by psychological factors (Kellner, 1994). Unlike
psychosomatic disorders, somatoform disorder is not a physically or medically identifiable or
testable illness. According to the DSM-IV diagnosis for Somatization Disorder (300.81), in order
for an individual to be diagnosed with the disorder the there must be a history of pain in at least
four different areas of the body as well as two gastrointestinal dysfunctions and one sexual
dysfunction (American Psychiatric Association, 2000). Somatoform disorder typically results in
functional and/or social impairment (Barsky, Orav, & Bates, 2005). Physicians report
somatoform disorder as difficult to treat and patient dissatisfaction for the treatment of
somatoform disorder is high (Kroenke et al, 1997).
Several studies have shown somatoform disorder to be very prevalent in the United States
(De Waal, Arnold, Eekhof, & Van Hemert, 2004; Kroenke et al, 1997; Roca et al, 2009).
Somatoform disorder affects 10 to 15 % of primary care patients (Kroenke et al, 1997). In a twostage prevalence study with 1,046 patients of general practitioners, somatoform disorder was
found to have a prevalence of 16.1 %. When only mild impairment cases were included, the
prevalence reached a high of 21.9 %. In the same study, those with somatoform disorders were
3.3 times more likely to have a comorbidity with anxiety and depressive disorders than expected
(De Waal, Arnold, Eekhof, & Van Hemert, 2004; Roca et al, 2009). A study done by Roca et al
(2009) showed somatoform to be the most prevalent psychiatric disorder in Spain even compared
with diagnoses of depression and anxiety.
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Somatoform disorder accounts for approximately 1 billion dollars of the expenses in
America’s current health care system annually (Barsky, Orav, & Bates, 2005) and Americans
with somatoform disorder have nine times more medical expenses than the average American
(Harvard, 2009). No differences in prevalence by gender, age, or ethnicity have been found.
With such a high prevalence of somatoform disorder in the United States and its high medical
costs, it is imperative that research be done on the best, cost-effective method of treatment in
order to reduce medical costs for both individuals and for America’s health care system.
Starting at the turn of the century, health care professionals began turning to
psychotherapy for treatment of somatoform disorders (Kroenke & Swindle, 2000). Several
studies have tested the treatment outcomes of psychotherapy treatment modalities such as
cognitive behavioral and psychodynamic therapies (Allen, Woolfolk, Escobar, Gara, & Hamer,
2006; Harvard, 2009; Kraft, Puschner, Lambert, & Kordy, 2006; Kroenke, 2007; Kroenke &
Swindle, 2000; Sumathipala, 2007; Tazaki and Landlaw, 2006). Cognitive behavioral therapy
has been shown to be an effective treatment modality for reducing somatic complaints and
improving the overall functionality of somatoform patients (Allen et al, 2006; Harvard, 2009;
Kraft et al, 2006; Kroenke, 2007; Kroenke & Swindle, 2000; Sumathipala, 2007; Tazaki and
Landlaw, 2006).
Although several studies have examined the effectiveness of psychotherapy treatments
for somatoform disorders, no research has examined the cost-effectiveness for treatment of
somatoform by license type of the therapy provider. Crane and Payne (in press) found
significant differences in the outcome and costs for different types of mental health provider
types across multiple mental health diagnoses. Using the number of sessions, dropout rates, cost,
and recidivism data, Crane and Payne found that the cost-effectiveness of treatment was ranked
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with professional counselors as the most cost-effective followed by marriage and family
therapists (MFT’s) and medical doctors (MD’s), Master’s social workers (MSW’s), followed by
Master’s level nurses. The least cost-effective were psychologists. The purpose of the present
study is to compare the cost-effectiveness of the treatment of somatoform disorder by profession
for the six above mentioned nationally licensed mental health professions in a managed care
environment in order to reduce costs for the treatment of somatoform disorder for the United
States health care systems, patients, and insurance companies. If Master's level providers can
treat these patients as effectively as more expensive providers, there could be significant cost
savings in health care.
Review of Literature
Background
Physical symptoms with no medical explanation have been present throughout history.
For the last 200 hundred years these symptoms have been traced to a psychological foundation
with little knowledge of its origins. For decades, researchers have attempted to develop a theory
that explains this psychological phenomenon. According to Brown (2004) medically
unexplained symptoms have historically been explained by theories of dissociation, conversion,
and recently by theories of somatization. Brown (2004) created an integrated model, using the
above mentioned theories, attributing somatoform disorder to the wrong selection of cognitive
information during attentional and control processing. More specifically, Brown attributes
somatic complaints to attention focused on symptom(s). This is created or maintained by various
biological and psychosocial elements including but not limited to negative affect, personality,
beliefs, behaviors, misinterpretations, and worry.
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Psychotherapy
Cognitive Behavioral Therapy. To this day, researchers are continuing to try and
understand the psychological and physiological origins of somatoform disorder. With so many
unknowns, physicians and mental health providers have found somatoform disorder difficult to
treat. At the beginning of the 21st century researchers began looking at psychotherapy treatment
for somatoform disorder. The most effective of these seems to be Cognitive-Behavioral Therapy
(CBT). In a review of 34 randomized controlled trials, CBT was shown to be the most effective
form of treatment for various somatoform disorders and somatization compared to
antidepressants, primary care physician consultations, nurse care management interventions, and
other forms of therapy (Kroenke, 2007). With a median of 8 sessions for the treatment, CBT was
shown to reduce symptoms of somatoform disorder in 11 out of 13 clinical trials.
In a large review of 13 systematic reviews and 421 randomized controlled trials in
primary, secondary, and tertiary settings, the effectiveness of various treatments for somatoform
disorders and somatization were compared. The review looked at antidepressants, cognitivebehavioral therapy (CBT), psychodynamic therapy, family therapy, and consultation letters. CBT
was more effective in improving physical and social functioning than the other treatments and
has been shown to reduce physical symptoms of somatoform disorder and reduce psychological
distress (Sumathipala, 2007). In fact, 31 of the randomized controlled studies that produced
evidence for CBT as an efficacious treatment for somatoform disorder were critically reviewed
by Kroenke and Swindle (2000). Physical symptoms, psychological distress, and functional
status were assessed and results showed that patients treated with CBT did better in these three
areas than the control patients in 22 (or 71%) of the studies.
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In 2006, Allen et al conducted a study using eighty four individuals diagnosed with
somatoform disorder. The individuals were randomly assigned into one of two groups with the
first group receiving a standard medical care with psychiatric consultation while the second
group received a 10 session CBT treatment. The Clinical Global Impression Scale for
Somatization Disorder, self-report, health care utilization, and clinical ratings were used to
determine outcome. Outcome was measured at baseline as well at 3, 9, and 15 months. The
CBT group showed far greater improvement than those receiving standard medical care. After
fifteen months, those treated with CBT reported a greater decrease in health care cost, better
functioning, and a reduction of somatic symptoms. These individuals were also more likely to
receive higher clinical ratings of improvement as well as .84 less points on the Clinical Global
Impression Scale than those in the standard medical group indicating a move toward a nonclinical range of symptoms.
Family Therapy. Family therapy is a treatment modality that has been used to treat
various individual mental health diagnoses (Kaslow, 2000). Unfortunately, little research has
been done to explore the efficacy of family therapy for the treatment of somatoform disorder.
One study conducted by Real et al. (1996) used family therapy for 18 patients who suffered from
somatoform disorder for 1 year or more. Brief strategic family therapy was given to all 18
patients with sessions ranging from 1 to 11 with an average of 4.6 sessions. Success was
achieved in 61.1 % of the patients who received family therapy with 27.8 % failure and an 11.1
% dropout rate.
Cost
Somatoform disorder is a difficult and expensive disorder to treat making health care
costs high for patients and the health care system. Crane and Payne (in press) found significant
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differences in the outcome and costs for different types of mental health provider types across
multiple mental health diagnoses. These differences in both outcome and costs could help the
insurance providers find the most successful treatment provider for somatoform patients thereby
decreasing costs. Unfortunately, no studies have been done on the treatment outcomes of
somatoform disorder by provider type.
Drop-Out & Cost
Drop-out can affect the outcomes and cost of treatment. Wierzbicki and Pekarik (1993)
define drop-out as “premature termination” in psychotherapy services. After reviewing over 125
studies on psychotherapy drop-out rates, Wierzbicki and Pekarik found the average
psychotherapy dropout rate to be 46.86 %. Hamilton, Moore, Crane, and Payne (2010) also
found that the dropout rate for mental health diagnoses is relatively high. Using data for over
434, 317 patients from CIGNA Behavioral Health, these researchers examined dropout rates by
diagnosis, therapy modality, and provider type. Results showed that mood disorders have a
higher dropout rate than other diagnoses, marriage and family therapists (MFTs) have the lowest
dropout rate by profession, and that individual therapy has fewer dropouts than family therapy
approaches. Unfortunately, even with the prevalence of such dropout research no research on
dropout rates for the treatment of somatoform disorder has been located. When clients of
somatoform disorder elect to drop-out of psychotherapy treatment, many of these clients may be
returning to receive other more costly forms of clinical and diagnostic services such surgeries
and exploratory procedures. Health care costs could benefit from keeping patients of
somatoform disorder in psychotherapy treatment, in order to reduce the use of these other more
costly methods of treatment.
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With so much research located on the effectiveness of treatment for somatoform disorder,
it is surprising that no research has been published on the cost of treatment for somatoform
disorder. The question still remains of how to best reduce the cost of treatment for such a
prevalent disorder. The present study seeks to better answer that question by looking at the
cost-effectiveness of treatment for somatoform disorder by profession.
Research Questions
Although CBT has been studied regarding the cost effectiveness of various treatment
modalities for somatoform disorder, little has been studied regarding the cost effectiveness of the
treatment of somatoform by profession. Determining cost-effectiveness of the treatment of
somatoform by profession may help indicate whether less costly (MS) professions (e.g. MFT’s,
MSWs, Master’s Nurses) can provide successful treatment for somatoform compared with the
more costly (Doctoral) professions (e.g. psychologists, MDs), as well as improve drop-out and
recidivism rates keeping somatoform patients out of other more costly medical procedures and
services, thereby lowering the cost of the treatment of somatoform disorder overall. The
following research questions will help to fill this gap in the literature:
1. What are the total number of sessions and total cost in the first Episode of Care for
somatoform disorder across all professions?
2. What are the number of sessions and cost of the first Episode of Care by profession for
Somatoform disorder?
3. Is there a difference in total cost and cost per session of the first Episode of Care by
profession for somatoform disorder?
4. Which profession has the lowest drop-out rate for somatoform disorder?
5. Which profession has the lowest recidivism rate for somatoform disorder?
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6. Is there a difference in drop-out and recidivism rates for provider degree level (Master’s,
vs. doctorate)?
Method
Sample
Subjects were taken from CIGNA, one of the top insurers of health care in the United
States. Claims for the clients diagnosed with somatoform disorder (DSM-IV 300.81) as the
primary diagnosis who were insured by CIGNA from six years of data (2001-2006) are included
in this study.
Each entry or line represents one claim filed by a therapist. These claims lines contain the
following information:
1.

A patient identification number unique to each patient.

2.

Date of outpatient service

3.

Amount paid for the claim

4.

ICD 9 diagnoses

5.

Patient gender

6.

Patient's age on date of service.

7.

Service location by U.S. state

8.

Outpatient type of service (individual therapy (90806), family therapy (90847))

9.

Number of outpatient visits billed

10.

Provider license(s)

The subjects represent the entire population of U.S. patients receiving outpatient mental
health care managed by CIGNA for somatoform disorder from 2001 to 2006. The claims for
somatoform disorder were 149 (N=149). The age range for patients in the data set is from 6 to 72
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(M= 33.91, SD= 17.03). The data set contained 103 females and 46 males. Patients from a
majority of the fifty states were included in the data.
The use of this data is permitted by the Health Insurance Portability and Accountability
Act of 1996 (HIPAA) regulations for protecting personal health care information. It is not
possible to identify any unique subscriber or provider information from the data provided. A
unique and nonidentifiable client identification number was put in place for each patient before
the data was examined in this study.
Therapist licenses are reported in the data for 6 different nationally recognized, specific
licenses including professional counselors (LPC), marriage and family therapists (MFT), MDs,
psychologists, nurses, social workers and psychiatrists. These six specific license types were
selected because they are nationally recognized as independently licensed health care
practitioners.
Data
The six years of data were combined in a database where each patient was assigned a
unique patient ID. For a complete explanation of the data cleaning procedure see Crane and
Payne (in press). The sample included 149 patients diagnosed with somatoform disorder from
2001 to 2006. In order to keep the sample homogeneous, only individuals with somatoform
disorder (DSM-IV 300.81) are included, not individuals with unspecified symptoms (DSM-IV
300.82).
Definitions and Procedure
Episodes of Care (EoC). According to CIGNA EoC is defined as a series of services for
the same patient that is continuous. An EoC began with the first psychotherapy service and

9

ended once the individual had no psychotherapy claims for 90 days or more. The number of
sessions in the first EoC per patient in the data set ranged from 1 to 73 (M=9.09, SD=13.25).
Success and Recidivism. Success and recidivism are calculated from the first EoC for the
purposes of this study. Success in terms of recidivism is defined as those patients who used only
one EoC within the time frame of the study (6 years). Recidivism is defined as any patient who
returned to therapy for a second EoC with the same provider type and the same DSM-IV
diagnosis.
Drop-Out. Drop-outs are defined as individual who attend one treatment session and did
not return for treatment for any reason (Hamilton et al, in press). Success in terms of drop-out is
defined as patients who return for more than one session during the first EoC.
Services and Diagnoses. Psychotherapy charges billed for individual or family therapy
were available in the data. The claims were classified by providers under the Current Procedural
Terminology (CPT) codes of individual psychotherapy (90806) or family psychotherapy (90847)
(American Medical Association, 2006). Due to the few cases of somatoform disorder using
family psychotherapy (n=13) analyses comparing family psychotherapy to individual
psychotherapy were not conducted.
Cost. Treatment cost is calculated by multiplying the total number of treatment sessions
per patient by the amount in dollars paid by CIGNA to the treatment provider per session. Total
cost represents payments for sessions in the first EoC.
Preliminary Analyses
Preliminary analyses revealed that the sample size was too small to effectively use binary
logistic regression to determine control variables. Instead, a chi square analysis was used in place
of binary logistic regression for research questions 3, 4, and 5. Out of the 149 claims of
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somatoform disorder as a primary diagnosis, 11 had an unknown provider type and were dropped
from analyses for questions 3, 4, and 5.
Preliminary analyses also revealed that cost and session data was positively skewed and
therefore breaks the assumptions for normality. To create a normal distribution a log
transformation of the cost variable and session variable was also included in analyses. These log
units create a log-normal distribution with the parameters being the expected mean of the
distribution and standard deviation (Limpert, Stahel, & Abbt, 2001). Both the literal data and log
normal data wielded the same statistical outcome.
Results
The first research questions asked, “What are the number of sessions and cost in the first
Episode of Care for somatoform disorder across all professions?” Descriptive statistics indicate
that the mean cost of treatment for somatoform disorder across all sessions is $557.16 (SD =
$1,113.93) with a minimum cost of $34, a maximum of $6,625. Log transformation of the data
showed the mean cost of treatment for somatoform disorder to be 5.47 (SD=1.19). Total number
of sessions for somatoform disorder psychotherapy across all professions ranged from 1 to 73 (M
= 9.09, SD = 13.25). Log transformation indicates a session mean of 1.56 (SD=1.10).
The second research question asked, “What are the number of sessions and cost in the
first Episode of Care by profession for Somatoform disorder?” Descriptive statistics indicate that
the cost for professional counselors ranged from $40 to $4,276 (M = $726.50, SD = $1, 144.48).
Log transformation indicated the cost for professional counselors ranged from 3.69 to 8.36
(M=5.7, SD=1.37). The number of sessions for professional counselors ranged from 1 to 70
sessions (M = 13.8, SD =19.36). Log transformation indicated a session mean of 1.89 (SD=1.23).
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The cost for MDs ranged from $85 to $5,477.50 (M=1,310.10, SD= 2,340.59). Log
transformation indicated a cost range of 4.44 to 8.61 (M=5.91, SD=1.72). Sessions for MDs
treating somatoform ranged from a minimum of 1 session to a maximum of 59 sessions (M=14.8,
SD= 24.88). Log transformation indicated a session mean of 1.55 (SD=1.69).
MSWs have a cost of treatment for somatoform disorder that ranged from a minimum of
$34 to a maximum of $1,113.76 (M=$267.56, SD=$280.89). Log transformation indicated a cost
range of 3.53 to7.02 (M=5.07, SD=1.04). Total sessions for MSWs who treated somatoform
disorder ranged from a minimum of 1 session to a maximum of 35 sessions (M=6.47, SD=7.27).
Log transformation indicated a session mean of 1.35 (SD=1.03).
MFTs cost of treatment ranged from a minimum of $34 a session to a maximum of
$1267.20 (M=$473.94, SD= 720.90) for treatment of somatoform disorder. Log transformation
indicated a cost range of 3.53 to 7.89 (M= 5.50, SD=1.17). Total session for MFTs who treated
somatoform disorder ranged from a minimum of 1 session to a maximum of 31 sessions (M=
8.67, SD= 8.7). Log transformation indicated a session mean of 1.71 (SD=1.04).
Psychologists mean cost of treatment ranged from a minimum cost of $35 to a maximum
of $2,310 (M=$365.75, SD= $399.11). Log transformation indicated a cost range of 3.56 to 7.75
(M=5.41, SD=0.99). Total sessions for psychologists treating somatoform disorder ranged from a
minimum of 1 session to a maximum of 39 sessions (M=6.58, SD=7.06). Log transformation
indicate a session mean of 1.44 (SD=0.95). Table 1 contains a summary of number of sessions
and cost in the first Episode of Care by profession for somatoform disorder.
There were no reported cases of somatoform treated by nurses.
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Table 1 About Here
The third question asked, “Is there a difference in total cost and cost per session of the first
Episode of Care by profession for somatoform disorder?” Due to the different degree level
providers being paid more than lower degree level providers (Master’s, doctorate) an ANCOVA
analyses was used to control for degree level. The ANCOVA revealed there is no significant
difference in total cost by profession F (5,137) = 1.57, p > .05. An ANCOVA did reveal that
MD’s had a significant difference in cost per session from all the other provider types F (5,137)
= 8.59, p < .05.
The fourth question asked, “Which profession has the lowest drop-out rate for somatoform
disorder? Descriptive statistics indicate that counselors have the lowest drop-out rate with 6.67%
followed by psychologists with a 15.28% drop-out rate. MFTs have a 16.67% followed by
MSWs with a 20.59% drop-out rate. MDs had a 40% drop-out rate. A chi square analysis also
revealed no statistically significant differences in drop-out rates across the six different license
types  2 (1, N = 149) = 4.047 p >.05.
The fifth research question asked, “Which profession has the lowest recidivism rate for
somatoform disorder?” Descriptive statistics show MSWs to have the lowest recidivism rate by
profession for somatoform disorder with a recidivism rate of 20.59 %. They are followed by
psychologists with a recidivism rate of 22.22%. Counselors have a recidivism rate of 26.67%,
followed by MDs with a 40% recidivism rate, and MFTs with the highest recidivism rate of 50%.
With such a large range of recidivism rates, it may be expected that a statistically significant
difference would be found. Yet, a chi square analysis revealed no statistically significant
differences in recidivism rates across the six different license types  2 (1, N = 149) = 5.567 p
>.05. A power analysis, assuming a large effect size of .35, indicated a sufficient power of .93
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for a sample size of 138. The data also meets the assumption of a chi square test with a
frequency of 5 or more in each cell (MSWs n=34, psychologists n=72, counselors n=15, MDs
n=5, MFT n =12).
The final research question asks, “Is there a difference in drop-out and recidivism rates
for provider degree level (Master’s, doctorate)?” A chi square analysis revealed no statistical
significant differences between Master’s level providers and doctorate level providers in dropout  2 (1, N = 149) = 0.091 p >.05, or recidivism rates  2 (1, N = 149) = 0.66 p >.05. Table 2
contains a summary of drop-out and recidivism rates for the first Episode of Care by profession
and provider degree level for somatoform disorder.
Table 2 About Here
Discussion
Crane and Payne (in press) found that the highest recidivism rate was an average of
15.8% across all mental health disorders. Data from the present study found that the recidivism
rates for somatoform across professions ranged from 20.95% to 50% which is high in
comparison. This could indicate that psychotherapy for somatoform disorder is less effective
than for other mental health diagnoses and somatoform patients are returning for more rounds of
treatment. So the effect of psychotherapy may be less durable for this type of problem. The
nature of somatoform disorder is such that symptoms are unexplainable and untestable. This
may prove difficult for mental health providers to pinpoint a specific treatment. Because of the
lack of origin or biological evidence as well as difficulty of treatment, many somatoform patients
may experience feelings of skepticism from providers which may lead them to seek treatment
from multiple providers across multiple disciplines.
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Kroenke et al (1997) found that physicians report somatoform disorder as difficult to
treat. The findings from this current study support this evidence that somatoform disorder is
difficult to treat for psychotherapists as well. The total number of sessions for somatoform
disorder (M=9.09, SD=13.25) across all professions was slightly higher than for other mental
health disorders (M= 6.95, SD= 8.91), as reported in Crane and Payne (in press).
There is little research on the cost of treatment for somatoform disorder. Results indicate
that there is no difference in total cost by profession. MDs had fewer sessions making no
statistical difference in total cost, but analyses of cost per session did indicate that MDs, on
average, charge more per session for treatment of somatoform disorder. But are the few sessions
with MDs sufficient enough for a successful outcome? Hansen, Lambert, and Forman (2002) in
their review of clinical trials and summary of literature found that literature suggests between 13
to 18 sessions is necessary for 50% of clients to improve. Unfortunately, no research has been
done on the amount of session necessary for successful outcomes for somatoform disorder.
Future research would be beneficial in determining what a “successful” amount of sessions may
be for treatment of somatoform disorder to see the implications of MDs cost per session.
Analyses of the dropout rates by profession in the current study were consistent with the
drop-out rates by profession with other mental health disorders. Hamilton et al. (in press) found
the range of drop-out rates to be 19.08 % to 49.12% across all DSM-IV diagnoses. Results from
the present study showed a similar range of drop-out rates by profession for somatoform disorder
from 6.67 % (counselors) to 40 % (MDs). This could indicate that patients with somatoform
disorder are not more likely to terminate from treatment prematurely as compared with other
mental health diagnoses.
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Research suggests that Master’s level clinicians are paid less than doctoral level
clinicians in the current mental health field (Finno et al. 2010). Results from the current study
suggest that Master’s level providers are as effective as doctoral level providers in treating
somatoform disorder. If more patients with somatoform disorder receive successful treatment
from Master’s level providers, this could decrease the overall cost of treatment of somatoform
disorder. It could be beneficial for insurance providers to have Master’s level mental health
providers for somatoform disorder because it would help reduce costs.
Evidence suggests that somatoform disorder is a prevalent disorder in the world’s health
care system (De Waal et al, 2004; Kroenke et al, 1997; Roca et al, 2009). Kroenke et al (1997)
found that somatoform disorder affects 10 to 15% of primary care patients. Another study,
showed a prevalence rate of 21.9%. The number of somatoform diagnoses in the data used for
the current study does not support this evidence. With over 10 million entries, there are only 149
cases of somatoform disorder which is less than 1% of the mental health cases reimbursed by
CIGNA Health Solutions. This could be due to somatoform disorder being under diagnosed.
Those diagnosed with somatoform disorder may not be seeking psychotherapy treatment. Many
clinicians may not be educated or trained in the symptoms of somatoform disorder or effective
treatment options. The current study only looked at primary diagnoses. It is possible that several
clients have somatoform disorder as a secondary or tertiary diagnosis. Finally, it may be that
clients are seeking alternative clinical and diagnostic services that could pose a larger cost for
health care providers. Future research should look at why the disorder is under diagnosed and/or
what can be done to keep or bring more of the disorder into psychotherapy treatment.

16

Limitations
Limitations for this study included the small sample size (N=149). A future study would
benefit from a larger sample size that would allow for binary logistic regression analyses to
predict outcomes. With the possibility of somatoform disorder being under diagnosed, this may
prove a difficult task. Given that the present larger data set included all psychotherapy services
in the CIGNA network, across six years, it is unlikely that larger number of patient would be
identified in normal health care utilization research. The research and clinical community could
benefit from becoming more aware of somatoform disorder and its symptoms as well as learning
about resources and clinicians who specialize in the treatment of the problem. Specialization
clinics could team up with researchers to conduct research aimed at developing better treatment
options for somatoform disorder.
The current study utilized a retrospective analysis of administrative data. Future studies
would benefit from utilizing an experimental design. Such a design would allow for random
assignment to each profession (professional counselor, MD, Master’s nurse, MSW, MFT,
psychologist). In the existing data, clients may not have had equal access to each provider type
or they may have self selected in any number of ways.
This study measured treatment success using drop out and recidivism. It is possible that
successful treatment could occur in one session. Based on the definitions of success used in this
study, these cases would not be included as successful outcomes. Future studies would benefit
by expanding the definition of success to include client and therapist self-report and clinical
significance.
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Conclusion
Somatoform is a prevalent and expensive disorder. Research suggests it is difficult to
treat and patients report high dissatisfaction with treatment. This study found that Master’s level
mental health providers are as effective as doctorate level mental health providers which could
save insurance companies and the countries health care money each year. Contrary to research
that suggests a high prevalence rate for somatoform disorder, the current study showed a low
prevalence rate. This may suggest somatoform disorder is underdiagnosed or that clients are
seeking alternative medical and diagnostic services that could potentially be more costly for
clients and insurance providers. Continued research and awareness of somatoform disorder
would be beneficial to clinicians and providers.
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Table 1. Number of Sessions and Cost by Profession

Counselor
N Sessions
15
Mean Sessions
13
SD Sessions
19.45
Min Sessions
1
Max Sessions
70
LN Mean Session
1.89
LN SD Session
1.23
Mean Cost
$726.25
SD Cost
$1,144.48
Min Cost
$40.00
Max Cost
$4,276.00
LN Mean Cost
5.7
LN SD Cost
1.37

MD
MFT
MSW Psychologist
5
12
34
72
14.8
8.67
6.47
6.58
24.88
8.7
7.27
7.06
1
1
1
1
59
31
35
39
1.55
1.71
1.35
1.44
1.69
1.04
1.03
0.95
$1,310.10 $473.94
$267.56
$356.75
$2,340.59 $720.90
$280.89
$399.11
$85.00
$34.00
$34.00
$35.00
$5,477.50 $1,267.25 $1,113.76 $2,310.00
5.91
5.5
5.07
5.41
1.72
1.17
1.04
0.99
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Table 2. Drop-Out and Recidivism by Profession and Degree Level
Provider Type

N

Counselor
MD
MFT
MSW
Psychologist

15
5
34
12
72

Drop-Out Recidivism Degree
Level
6.67%
26.67% Master’s
40.00%
40.00% Doctorate
16.67%
50.00%
20.59%
20.59%
15.28%
22.22%
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N
89
60

Drop-Out Recidivism
15%
16.90%

28.30%
22.50%

